← FDA Drug Approvals (Drugs@FDA)
LEVOCARNITINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2021-11-10
Drug application
- FDA Application #
ANDA212533- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LEVOCARNITINE
- Generic name
- LEVOCARNITINE
- Active ingredients
- LEVOCARNITINE
- Dosage form
- SOLUTION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SCIEGEN PHARMS
- Manufacturer
- TRUPHARMA, LLC
- First approval
- 2021-11-10
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown